Trading Signals: ATRA Stock Price Prediction and Forecast (Mon. Oct. 26, 2015 - Wed. Sep. 14, 2022)(Atara Biotherapeutics, Inc.)
| ATRA latest price $7.9200 (-4.46%) ($7.4500 - $8.0600) on Fri. May. 1, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 7.96% (three month average) | RSI | 47 | Latest Price | $7.9200(-4.46%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | ATRA declines -2.2% a day on average for past five trading days. | Weekly Trend | ATRA advances 0.4% a week on average for past two weeks. | Market Behavior | Broad based sell-off for large cap. Broad based sell-off for small cap. | Correlated ETFs | Broad market will support ATRA advance at 0% a week (0% probability) XBI(53%) ARKG(46%) IBB(45%) ARKK(43%) IWO(42%) | Factors Impacting ATRA price | ATRA will decline at least -3.98% in a week (0% probabilities). VIXM(-31%) VXX(-28%) UNG(-10%) UUP(-8%) TLT(-7%) | | | | | Relative Volatility | | | | Market Trend Strength | -3.98% (StdDev 7.96%) | Hourly BBV | 0 () | Intraday Trend | -1.4% | | | |
|
Resistance Level | $8.31 | 5 Day Moving Average | $8.48(-6.6%) | 10 Day Moving Average | $8.42(-5.94%) | 20 Day Moving Average | $8.31(-4.69%) | To recent high | -47.1% | To recent low | 39.2% | Market Cap | $589m | | | | Atara Biotherapeutics, Inc. operates as a clinical stage company, which engages in the development of novel therapeutics for patients with cancer, autoimmune, and viral diseases. Its pipeline includes Tab-cel, ATA188, ATA2271/ATA3271, and ATA3219. The company was founded by Isaac E. Ciechanover on August 22, 2012 and is headquartered in South San Francisco, CA. |